http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110804016-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-227 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110804016-B |
| titleOfInvention | Diarylquinoline derivatives against Mycobacterium tuberculosis |
| abstract | The invention discloses a substituted diarylquinoline derivative represented by the general formula I, and a salt added thereto with a pharmaceutically acceptable acid or base. The compounds of the present invention are useful in the treatment of mycobacterium tuberculosis diseases, particularly diseases caused by pathogenic mycobacteria such as Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium avium, Mycobacterium marinum. The definition of the compound of the present invention is as follows: R 1 is phenyl and naphthyl containing cyclopropyl and cyclopropyl derivatives, 3-hydroxypropene or propyn-1-yl; R 2 is Br; R 1 is benzene In the case of base and substituted phenyl, naphthalene-1-base, R 2 is 3-hydroxypropene or propyn-1-base containing cyclopropyl and cyclopropyl derivatives; . |
| priorityDate | 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.